Home > > > > > Report Detail

Rosacea - Epidemiology Forecast to 2028

Publisher Name :
Date: 15-Jan-2019
No. of pages: 50
Delivery of the Report will take 2-3 working days once order is placed.

DelveInsight's "Rosacea - Epidemiology Forecast, 2028" report provides a comprehensive analysis of the Rosacea epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2028.

Markets Covered

- United States

- EU5 (Germany, France, Italy, Spain, and the United Kingdom)

- Japan

Study Period: 2016-2028

Rosacea Epidemiology

The epidemiology section covers the historical, current as well as forecasted epidemiology for Rosacea in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders' views are also taken into account to provide a deep understanding of the Rosacea outlook. It also includes the explanation of changing trends of epidemiology outlining the Rosacea scenario.

Rosacea Epidemiology Segmentation

The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Rosacea thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.

Report Scope

- The report covers detailed overview of Rosacea explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns

- It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan

- The Rosacea Report assesses the disease risk and burden and highlights the unmet needs

- It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

Key strengths

- 10 Year Forecast

- 7MM Coverage

- Total Cases in Rosacea

Key assessments

- Patient Segmentation in Rosacea

- Rosacea Risk & Burden

- Factors driving growth in a specific Rosacea patient population

Rosacea - Epidemiology Forecast to 2028

Table of Contents

1. Report Introduction
2. Rosacea Epidemiology Overview at a Glance
2.1. Patient Share Distribution of Rosacea in 2016
2.2. Patient Share Distribution of Rosacea in 2028
3. Disease Background and Overview: Rosacea
3.1. Introduction
3.2. Symptoms
3.3. Etiology
3.4. Risk Factors
3.5. Pathophysiology
3.6. Diagnosis
3.7. Treatment
4. Epidemiology and Patient Population
4.1. Key Findings
4.2. Total Prevalent/ Incident Patient Population of Rosacea in 7MM
4.3. Total Prevalent/ Incident Patient Population of Rosacea in 7MM - By Countries
5. Epidemiology of Rosacea by Countries
5.1. United States
5.1.1. Assumptions and Rationale
5.1.2. Prevalent/Incident Cases of the Rosacea
5.1.3. Sub-Type Specific cases of the Rosacea *
5.1.4. Sex- Specific Cases of the Rosacea *
5.1.5. Diagnosed Cases of the Rosacea
5.2. EU5
5.3. Assumptions and Rationale
5.4. Germany
5.4.1. Assumptions and Rationale
5.4.2. Prevalent/Incident Cases of the Rosacea
5.4.3. Sub-Type Specific cases of the Rosacea *
5.4.4. Sex- Specific Cases of the Rosacea *
5.4.5. Diagnosed Cases of the Rosacea
5.5. France
5.5.1. Assumptions and Rationale
5.5.2. Prevalent/Incident Cases of the Rosacea
5.5.3. Sub-Type Specific cases of the Rosacea *
5.5.4. Sex- Specific Cases of the Rosacea *
5.5.5. Diagnosed Cases of the Rosacea
5.6. Italy
5.6.1. Assumptions and Rationale
5.6.2. Prevalent/Incident Cases of the Rosacea
5.6.3. Sub-Type Specific cases of the Rosacea *
5.6.4. Sex- Specific Cases of the Rosacea *
5.6.5. Diagnosed Cases of the Rosacea
5.7. Spain
5.7.1. Assumptions and Rationale
5.7.2. Prevalent/Incident Cases of the Rosacea
5.7.3. Sub-Type Specific cases of the Rosacea *
5.7.4. Sex- Specific Cases of the Rosacea *
5.7.5. Diagnosed Cases of the Rosacea
5.8. United Kingdom
5.8.1. Assumptions and Rationale
5.8.2. Prevalent/Incident Cases of the Rosacea
5.8.3. Sub-Type Specific cases of the Rosacea *
5.8.4. Sex- Specific Cases of the Rosacea *
5.8.5. Diagnosed Cases of the Rosacea
5.9. Japan
5.9.1. Assumptions and Rationale
5.9.2. Prevalent/Incident Cases of the Rosacea
5.9.3. Sub-Type Specific cases of the Rosacea *
5.9.4. Sex- Specific Cases of the Rosacea *
5.9.5. Diagnosed Cases of the Rosacea
6. Unmet Needs of the Rosacea
7. Appendix
8. Report Methodology
8.1. Sources
9. DelveInsight Capabilities
10. Disclaimer
11. About DelveInsight
*Indication Specific

List of Tables

Table 1: Total Prevalent/Incident Cases of the Rosacea in 7MM
Table 2: Total Prevalent/Incident Cases of the Rosacea in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Rosacea in United States (2016-2028)
Table 4: Sub-Type Specific cases of the Rosacea in United States (2016-2028)*
Table 5: Sex- Specific Cases of the Rosacea in United States (2016-2028)*
Table 6: Diagnosed Cases of the Rosacea in United States (2016-2028)
Table 7: Prevalent/Incident Cases of the Rosacea in Germany (2016-2028)
Table 8: Sub-Type Specific cases of the Rosacea in Germany (2016-2028) *
Table 9: Sex- Specific Cases of the Rosacea in Germany (2016-2028) *
Table 10: Diagnosed Cases of the Rosacea in Germany (2016-2028)
Table 11: Prevalent/Incident Cases of the Rosacea in France (2016-2028)
Table 12: Sub-Type Specific cases of the Rosacea in France (2016-2028) *
Table 13: Sex- Specific Cases of the Rosacea in France (2016-2028) *
Table 14: Diagnosed Cases of the Rosacea in France (2016-2028)
Table 15: Prevalent/Incident Cases of the Rosacea in Italy (2016-2028)
Table 16: Sub-Type Specific cases of the Rosacea in Italy (2016-2028) *
Table 17: Sex- Specific Cases of the Rosacea in Italy (2016-2028) *
Table 18: Diagnosed Cases of the Rosacea in Italy (2016-2028)
Table 19: Prevalent/Incident Cases of the Rosacea in Spain (2016-2028)
Table 20: Sub-Type Specific cases of the Rosacea in Spain (2016-2028) *
Table 21: Sex- Specific Cases of the Rosacea in Spain (2016-2028) *
Table 22: Diagnosed Cases of the Rosacea in Spain (2016-2028)
Table 23: Prevalent/Incident Cases of the Rosacea in UK (2016-2028)
Table 24: Sub-Type Specific cases of the Rosacea in UK (2016-2028) *
Table 25: Sex- Specific Cases of the Rosacea in UK (2016-2028) *
Table 26: Diagnosed Cases of the Rosacea in UK (2016-2028)
Table 27: Prevalent/Incident Cases of the Rosacea in Japan (2016-2028)
Table 28: Sub-Type Specific cases of the Rosacea in Japan (2016-2028) *
Table 29: Sex- Specific Cases of the Rosacea in Japan (2016-2028) *
Table 30: Diagnosed Cases of the Rosacea in Japan (2016-2028)

List of Figures

Figure 1: Total Prevalent/Incident Cases of the Rosacea in 7MM
Figure 2: Total Prevalent/Incident Cases of the Rosacea in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Rosacea in United States (2016-2028)
Figure 4: Sub-Type Specific cases of the Rosacea in United States (2016-2028)*
Figure 5: Sex- Specific Cases of the Rosacea in United States (2016-2028)*
Figure 6: Diagnosed Cases of the Rosacea in United States (2016-2028)
Figure 7: Prevalent/Incident Cases of the Rosacea in Germany (2016-2028)
Figure 8: Sub-Type Specific cases of the Rosacea in Germany (2016-2028) *
Figure 9: Sex- Specific Cases of the Rosacea in Germany (2016-2028) *
Figure 10: Diagnosed Cases of the Rosacea in Germany (2016-2028)
Figure 11: Prevalent/Incident Cases of the Rosacea in France (2016-2028)
Figure 12: Sub-Type Specific cases of the Rosacea in France (2016-2028) *
Figure 13: Sex- Specific Cases of the Rosacea in France (2016-2028) *
Figure 14: Diagnosed Cases of the Rosacea in France (2016-2028)
Figure 15: Prevalent/Incident Cases of the Rosacea in Italy (2016-2028)
Figure 16: Sub-Type Specific cases of the Rosacea in Italy (2016-2028) *
Figure 17: Sex- Specific Cases of the Rosacea in Italy (2016-2028) *
Figure 18: Diagnosed Cases of the Rosacea in Italy (2016-2028)
Figure 19: Prevalent/Incident Cases of the Rosacea in Spain (2016-2028)
Figure 20: Sub-Type Specific cases of the Rosacea in Spain (2016-2028) *
Figure 21: Sex- Specific Cases of the Rosacea in Spain (2016-2028) *
Figure 22: Diagnosed Cases of the Rosacea in Spain (2016-2028)
Figure 23: Prevalent/Incident Cases of the Rosacea in UK (2016-2028)
Figure 24: Sub-Type Specific cases of the Rosacea in UK (2016-2028) *
Figure 25: Sex- Specific Cases of the Rosacea in UK (2016-2028) *
Figure 26: Diagnosed Cases of the Rosacea in UK (2016-2028)
Figure 27: Prevalent/Incident Cases of the Rosacea in Japan (2016-2028)
Figure 28: Sub-Type Specific cases of the Rosacea in Japan (2016-2028) *
Figure 29: Sex- Specific Cases of the Rosacea in Japan (2016-2028) *
Figure 30: Diagnosed Cases of the Rosacea in Japan (2016-2028)

  • Global Hyaluronic Acid Dermal Filler Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 88
    Hyaluronic Acid Dermal Filler are The product can be used to smooth away wrinkles and fine line, create fuller and more accentuated lips, and adding facial volume and contour. The global Hyaluronic Acid Dermal Filler market was valued at US$ 2682.8 million in 2023 and is anticipated to reach US$ 5035.7 million by 2030, witnessing a CAGR of 9.3% during The forecast period 2024-2030. The producers mainly located in Europe, United States, China and Korea, such as Allergan,......
  • Global Hyaluronic Acid Based Dermal Fillers Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 134
    According to our LPI (LP Information) latest study, the global Hyaluronic Acid Based Dermal Fillers market size was valued at US$ 2195.2 million in 2023. With growing demand in downstream market, the Hyaluronic Acid Based Dermal Fillers is forecast to a readjusted size of US$ 3708.9 million by 2030 with a CAGR of 7.8% during review period. The research report highlights the growth potential of the global Hyaluronic Acid Based Dermal Fillers market. Hyaluronic Acid Based Dermal Fillers ar......
  • Global Dermal Fillers Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 112
    According to our LPI (LP Information) latest study, the global Dermal Fillers market size was valued at US$ 5342.2 million in 2023. With growing demand in downstream market, the Dermal Fillers is forecast to a readjusted size of US$ 15850 million by 2030 with a CAGR of 16.8% during review period. The research report highlights the growth potential of the global Dermal Fillers market. Dermal Fillers are expected to show stable growth in the future market. However, product differentiation,......
  • Global Hyaluronic Acid Dermal Filler Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 115
    According to our LPI (LP Information) latest study, the global Hyaluronic Acid Dermal Filler market size was valued at US$ 2624.4 million in 2023. With growing demand in downstream market, the Hyaluronic Acid Dermal Filler is forecast to a readjusted size of US$ 5000.7 million by 2030 with a CAGR of 9.6% during review period. The research report highlights the growth potential of the global Hyaluronic Acid Dermal Filler market. Hyaluronic Acid Dermal Filler are expected to show stable gr......
  • Global Pressure Ulcer Treatment Products Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 118
    According to our LPI (LP Information) latest study, the global Pressure Ulcer Treatment Products market size was valued at US$ 2150.3 million in 2023. With growing demand in downstream market, the Pressure Ulcer Treatment Products is forecast to a readjusted size of US$ 3021.5 million by 2030 with a CAGR of 5.0% during review period. The research report highlights the growth potential of the global Pressure Ulcer Treatment Products market. Pressure Ulcer Treatment Products are expected t......
  • Global Dermatology Drug Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 108
    According to our LPI (LP Information) latest study, the global Dermatology Drug market size was valued at US$ million in 2023. With growing demand in downstream market, the Dermatology Drug is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Dermatology Drug market. Dermatology Drug are expected to show stable growth in the future market. However, product differentiation, reducing ......
  • Global Pruritus Therapeutics Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109
    According to our LPI (LP Information) latest study, the global Pruritus Therapeutics market size was valued at US$ 13380 million in 2023. With growing demand in downstream market, the Pruritus Therapeutics is forecast to a readjusted size of US$ 17790 million by 2030 with a CAGR of 4.1% during review period. The research report highlights the growth potential of the global Pruritus Therapeutics market. Pruritus Therapeutics are expected to show stable growth in the future market. However......
  • Global Scar Treatment Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109
    According to our LPI (LP Information) latest study, the global Scar Treatment market size was valued at US$ 956.9 million in 2023. With growing demand in downstream market, the Scar Treatment is forecast to a readjusted size of US$ 1584.4 million by 2030 with a CAGR of 7.5% during review period. The research report highlights the growth potential of the global Scar Treatment market. Scar Treatment are expected to show stable growth in the future market. However, product differentiation, ......
  • Global Botox Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 92
    According to our LPI (LP Information) latest study, the global Botox market size was valued at US$ 4597.8 million in 2023. With growing demand in downstream market, the Botox is forecast to a readjusted size of US$ 9055 million by 2030 with a CAGR of 10.2% during review period. The research report highlights the growth potential of the global Botox market. Botox are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain opt......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs